Acute Upper Limb Ischaemia
Acute upper limb ischaemia is a sudden reduction in arterial supply to the arm or hand, usually from an embolus. Collaterals may keep the hand alive without preserving useful function. Assess threat, inflow and cause; start heparin unless contraindicated and plan reperfusion. New ischaemic weakness demands immediate action. Most patients need arterial imaging, but a clearly embolic, immediately threatened arm with a palpable proximal pulse may proceed directly to embolectomy. After restoring flow, find the source and prevent recurrence. [1–3]
Written August 15, 2026 · Mr Razhan K Ali
1 · UNDERSTAND — Causes and presentation
Recognise the pattern
Embolism usually causes abrupt symptoms in a previously functioning arm. Atrial fibrillation (AF) and other cardiac sources are common; the brachial bifurcation is a frequent site of impaction. Local arterial disease includes thrombosis, a subclavian or axillary aneurysm, arterial thoracic outlet syndrome, vasculitis and radiation injury. Recent trauma, arterial instrumentation or dialysis access changes the diagnostic pathway. Chest or back pain, or an absent or unusually prominent proximal pulse, should raise concern for aortic or proximal arterial disease rather than a simple brachial embolus. [1–3]
Shoulder and elbow collaterals explain why tissue loss is less common than in the leg. They do not make neurological deficit safe to observe. Pain may be less striking than coldness, numbness or loss of hand function. [1,2]
Examine threat before chasing the source
Record and repeat sensation, finger and wrist power, muscle tenderness, temperature, colour and capillary refill. Compare axillary, brachial, radial and ulnar pulses and assess wrist/hand Doppler signals. A proximal pulse helps localise the obstruction; it does not establish adequate hand perfusion. Ask about symptom onset, dominant hand, occupation and baseline independence. [1–3]
New weakness attributable to ischaemia means an immediately threatened limb. Profound anaesthesia with paralysis, rigidity or fixed mottling suggests irreversible injury and needs immediate senior assessment. Judge viability clinically, not from elapsed time, a Doppler signal or creatine kinase alone. [1,2]
2 · DECIDE — Assessment and treatment
Initial treatment
Give analgesia and IV unfractionated heparin unless contraindicated. ESVS describes an initial 5,000 IU or 70–100 IU/kg, followed by a monitored infusion. Follow the local protocol; account for existing anticoagulation and bleeding risk. Suspected heparin-induced thrombocytopenia requires a non-heparin strategy with haematology input. Suspected dissection or traumatic haemorrhage needs a cause-specific anticoagulation decision. [1,4]
Obtain IV access, ECG and baseline bloods, including haemoglobin, platelets, coagulation and renal function/electrolytes. Correct hypovolaemia without fluid overload and treat cardiac instability in parallel. Do not wait for echocardiography before treating a threatened arm. In UK networks, arrange direct vascular-hub assessment and time-critical transfer for new sensory or motor impairment. [1,2,5]
ESVS recommends supplemental oxygen while awaiting revascularisation. UK BTS guidance uses oxygen to achieve a prescribed saturation target, rather than routine liberal oxygen. Apply the UK/local oxygen policy; critical illness still requires immediate appropriate oxygen treatment. [1,6]
Image unless the narrow exception applies
Pre-operative imaging is the default. ESVS permits omission only with clear embolism + an immediately threatened limb + a palpable axillary or proximal brachial pulse. This can justify proceeding directly to brachial embolectomy; a palpable pulse alone is insufficient. Recommendation 56: Class I, Level C. [1]
Otherwise obtain urgent arterial imaging. Duplex may suffice when immediately available and anatomically conclusive; CTA is particularly useful for an absent proximal pulse, atypical presentation, aneurysm, dissection or an uncertain proximal source. Include the inflow vessels, not just the forearm. Coordinate imaging with treatment so that it does not create avoidable delay. Blind embolectomy in unexplained proximal disease can worsen the problem. [1–3]
Choose by threat and expected function
| Clinical situation | Management |
|---|---|
| Threatened but salvageable | Urgent revascularisation; immediate flow restoration for ischaemic motor deficit. An accessible embolus usually favours brachial embolectomy. Anatomy and expertise may favour an endovascular or hybrid approach. [1–3] |
| Stable, without neurological deficit or muscle tenderness, with preserved wrist Doppler signals | Selected patients may receive anticoagulation alone after discussion of procedural risk, functional consequences and preference. Reassess regularly over the next few days; deterioration requires urgent escalation. [1] |
| Viable hand but important functional limitation | Consider revascularisation despite low amputation risk. Dominance, work and activities needed for independence matter; frailty does not automatically mean low functional need. [1,2] |
| Confirmed irreversible ischaemia | Do not revascularise a confirmed non-viable limb. Decide on amputation or palliation with senior input and the patient's goals, providing active symptom control. [1,2] |
ESVS advises against anticoagulation alone when the arm is threatened or limb function is important to quality of life: Recommendation 57, Class III, Level C. Conservative care is a selected management plan, not simply “the arm has collaterals”. [1]
Paediatric exception: a supracondylar fracture with an absent pulse or impaired perfusion needs urgent fracture management. After reduction, a well-perfused pulseless hand may be observed with serial neurovascular checks; persistent ischaemia requires exploration. Deterioration requires immediate reassessment. Do not apply the adult embolic pathway or a one-week waiting rule to these children. [1,7]
3 · JUSTIFY — Evidence and treatment selection
The treatment target is a usable hand, not merely avoidance of amputation. Persistent exertional pain and loss of grip can justify restoring flow in an otherwise viable limb. Brachial embolectomy offers direct treatment of a typical accessible embolus; more complex disease requires an anatomical solution. [1–3]
Comparative evidence remains weak. A 2026 systematic review included 27 observational studies, with no randomised trials identified in its search to September 2025. Studies had high risk of bias and certainty was low to very low. Different case selection and outcome definitions prevent its pooled treatment-group results from establishing superiority. Choose by urgency, anatomy, bleeding risk, functional goals and available expertise—not by comparing uncontrolled pooled success rates. [8]
4 · PERFORM — Revascularisation principles
Restore inflow and hand perfusion
For a straightforward brachial embolus, local anaesthesia with an anaesthetist present is the usual approach. Explain the benefit, alternatives and material risks: bleeding, arterial or nerve injury, persistent/recurrent ischaemia, further reconstruction, compartment syndrome, loss of hand function or amputation, stroke and death. [1–3,9]
The essential operative principles are to obtain control, protect the median nerve, clear the obstructed inflow and assess both radial and ulnar outflow. Do not assume repeated catheter passes enter both forearm arteries or that retrieved clot proves clearance. Resistance, poor inflow or persistent hand ischaemia requires imaging and a revised plan, not force. Proximal clot manipulation also carries a risk of cerebral embolisation. Underlying arterial disease may require repair or bypass rather than embolectomy alone. [2,3,9,10]
Confirm reperfusion
Plan completion angiography. ESVS acute limb ischaemia guidance recommends completion angiography. The ESVS upper-limb section allows omission in selected straightforward cases when visible hand perfusion and a palpable wrist pulse return. This is a narrow exception, not permission to omit imaging after uncertain clearance or an unsatisfactory result. Document hand perfusion, neurological findings, distal signals and the reason for any omission. [1–3]
Use endovascular treatment selectively
Aspiration, mechanical thrombectomy or catheter-directed thrombolysis may suit selected proximal/distal disease or residual clot. Match the method to the required speed of reperfusion; do not choose a slow infusion strategy when immediate flow restoration is needed. Consider bleeding risk and cerebral embolisation from proximal clot or arch manipulation. Endovascular and open methods may be combined rather than treated as competing fixed pathways. [1,8,11]
During catheter-directed thrombolysis, continuous systemic therapeutic heparinisation is not recommended. Use the unit's dedicated thrombolysis and monitoring protocol rather than automatically continuing the initial therapeutic infusion. [1]
5 · MANAGE — Complications and secondary prevention
Watch for failure after reperfusion
| Problem | Recognise and act |
|---|---|
| Persistent ischaemia or re-occlusion | Continuing or recurrent coldness, pain, neurological deficit or loss of restored signals needs urgent reassessment. Check inflow, residual embolus, arterial injury, distal outflow and the culprit lesion; re-image or re-intervene promptly. Do not label a poor result “spasm” before excluding mechanical failure. [1–3,9] |
| Compartment syndrome | Escalating pain, pain on passive stretch, tense swelling or worsening neurology is concerning even with restored pulses. Established syndrome needs urgent, complete decompression of the involved compartments. Obtain hand/orthoplastic assistance where needed without delaying treatment. Prophylactic fasciotomy is not routine, but prolonged ischaemia with marked swelling after embolectomy warrants fasciotomy. [1,2,12] |
| Systemic reperfusion injury | After severe/prolonged ischaemia, monitor for hyperkalaemia, acidosis, arrhythmia, rhabdomyolysis and renal injury. Follow urine output and relevant blood tests and involve critical care when required. [1,2,12] |
Find the cause and prevent the next event
Investigate an embolic source with ECG, appropriate rhythm monitoring and echocardiography; assess the aorta when no intracardiac source is found. Treat a local source such as an aneurysm or arterial thoracic outlet lesion: removing its distal embolus does not remove the cause. [1–3]
After revascularisation for an embolus associated with AF or intracardiac thrombus, long-term anticoagulation is recommended. Without either, anticoagulation may be considered individually; lifelong treatment is not automatic. [1]
For atherosclerotic upper-limb disease, address smoking, lipid lowering and cardiovascular risk. Antithrombotic therapy after revascularisation should be individualised. Do not automatically import a lower-limb regimen or add an antiplatelet to full-dose anticoagulation without a separate indication. [1,4]
Before discharge, document the antithrombotic plan, source investigation, functional review and any procedure-specific imaging surveillance. Review pain on use, grip and daily activities; persistent disability warrants reassessment and rehabilitation even if the hand is viable. Recurrent pain, coldness, numbness or weakness requires urgent review. [1,2]
6 · REMEMBER — Key clinical takeaways
- Preserve function, not just tissue.
- New ischaemic weakness means immediate action.
- Start heparin unless contraindicated; investigate and treat in parallel.
- Omit pre-operative imaging only for clear embolism + immediate threat + palpable proximal pulse.
- Conservative treatment needs a functional assessment and repeated review.
- Clot retrieval is not proof of clearance; confirm hand perfusion.
- Restored pulses do not exclude compartment syndrome.
- Treat the embolic source and match secondary prevention to the cause. [1–4]
Assess threat. Define inflow. Restore function. Treat the source.
References
- Björck M, Earnshaw JJ, Acosta S, et al. Editor's Choice — European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59:173–218. doi:10.1016/j.ejvs.2019.09.006.
- Sidawy AN, Perler BA, eds. Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Elsevier; 2023.
- Loftus I, Hinchliffe RJ, eds. Vascular and Endovascular Surgery: A Companion to Specialist Surgical Practice. 7th ed. Elsevier; 2024.
- Twine CP, Kakkos SK, Aboyans V, et al. Editor's Choice — European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. Eur J Vasc Endovasc Surg. 2023;65:627–689. doi:10.1016/j.ejvs.2023.03.042.
- NCEPOD. Risking Life and Limb: A review of the quality of care provided to adults with acute limb ischaemia. 2025. Report and recommendations.
- O'Driscoll BR, Howard LS, Earis J, Mak V. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1):ii1–ii90. doi:10.1136/thoraxjnl-2016-209729. Current BTS guidance.
- British Orthopaedic Association. BOASt — Supracondylar Fractures of the Humerus in Children. Updated October 2020. Standards for practice.
- Lee AD, Iossifidis E, Harding C, et al. A Systematic Review and Meta-Analysis of Reported Success and Complication Outcomes the Management of Acute Upper Limb Ischemia. Ann Vasc Surg. 2026;133:510–522. doi:10.1016/j.avsg.2026.07.055.
- Forsyth JM. How to Be a Safe Consultant Vascular Surgeon from Day One: The Unofficial Guide to Passing the FRCS (VASC). 1st ed. CRC Press; 2023.
- Wind GG, Valentine RJ. Anatomic Exposures in Vascular Surgery. 3rd ed. Lippincott Williams & Wilkins; 2013.
- Schneider PA. Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery. 4th ed. CRC Press; 2020.
- Chaikof EL, Cambria RP, eds. Atlas of Vascular Surgery and Endovascular Therapy: Anatomy and Technique. Saunders; 2014.